{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:29:09Z","timestamp":1794572949352,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:00:00Z","timestamp":1577491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.pedneo.2019.12.009","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T02:33:40Z","timestamp":1578623620000},"page":"311-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-term outcomes of graves disease in children treated with anti-thyroid drugs"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-0072","authenticated-orcid":false,"given":"Ya-Ting","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsin","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Kang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chon-In","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2797-1128","authenticated-orcid":false,"given":"Bi-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hsu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Mei","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Jung","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann-Jinn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2019.12.009_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pedneo.2019.12.009_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.beem.2013.08.008","article-title":"Graves' disease in children","volume":"28","author":"L\u00e9ger","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.0.1300565","article-title":"Incidence of juvenile thyrotoxicosis in Denmark, 1982\u20131988. A nationwide study","volume":"130","author":"Lavard","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pedneo.2019.12.009_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European thyroid association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.pedneo.2019.12.009_bib5","series-title":"Williams textbook of endocrinology","first-page":"369","article-title":"Hyperthyroid disorders","author":"Davies","year":"2016"},{"key":"10.1016\/j.pedneo.2019.12.009_bib6","first-page":"310","article-title":"Graves' disease in childhood: advances in management with antithyroid drug therapy","volume":"71","author":"Kaguelidou","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.pedneo.2019.12.009_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jc.2011-1944","article-title":"Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study","volume":"97","author":"L\u00e9ger","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib8","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jc.2008-0842","article-title":"Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment","volume":"93","author":"Kaguelidou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib9","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1542\/peds.2007-1535","article-title":". Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study","volume":"121","author":"Glaser","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2019.12.009_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000320028","article-title":"Pediatric Graves' disease: controversies in management","volume":"74","author":"Rivkees","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.pedneo.2019.12.009_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpendmet0068","article-title":"Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission?","volume":"2","author":"Weetman","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","article-title":"Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years","volume":"64","author":"Lippe","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/thy.2012.0612","article-title":"Antithyroid drug treatment for Graves' disease in children: a long-term retrospective study at a single institution","volume":"24","author":"Ohye","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.pedneo.2019.12.009_bib14","first-page":"1131","article-title":"Long-term outcomes of pediatric Graves' disease","volume":"27","author":"Jevalikar","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000430985","article-title":"Increasing incidence of juvenile thyrotoxicosis in Denmark: a nationwide study, 1998\u20132012","volume":"84","author":"Havgaard Kj\u00e6r","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.pedneo.2019.12.009_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2265.1996.634454.x","article-title":"Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women","volume":"44","author":"Barlow","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pedneo.2019.12.009_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1875-9572(10)60014-9","article-title":"New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness","volume":"51","author":"Chen","year":"2010","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.pedneo.2019.12.009_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.endinu.2017.11.014","article-title":"Treatment of Graves' disease in children: the Portuguese experience","volume":"65","author":"Marques","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.pedneo.2019.12.009_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/thy.1997.7.755","article-title":"Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy","volume":"7","author":"Shulman","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.pedneo.2019.12.009_bib20","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1210\/jcem.85.10.6922","article-title":"Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients","volume":"85","author":"Lazar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib21","first-page":"220","article-title":"Outcome of antithyroid medication and radioiodine therapy in pediatric Graves' disease","volume":"44","author":"Leu","year":"2003","journal-title":"Acta Paediatr Taiwan"},{"key":"10.1016\/j.pedneo.2019.12.009_bib22","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2006-1402","article-title":"Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype","volume":"91","author":"Manji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib23","first-page":"427","article-title":"Independent pretreatment predictors of Graves' disease outcome","volume":"49","author":"Dauk\u0161ien\u0117","year":"2013","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.pedneo.2019.12.009_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2013.12.047","article-title":"Graves disease in children: thyroid-stimulating hormone receptor antibodies as remission markers","volume":"164","author":"Gastaldi","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2019.12.009_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.pedneo.2019.12.009_bib26","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1210\/jc.2013-4026","article-title":"Clinical relevance of thyroid-stimulating autoantibodies in pediatric Graves' disease-a multicenter study","volume":"99","author":"Diana","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1507\/endocrj.52.505","article-title":"Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease","volume":"52","author":"Shibayama","year":"2005","journal-title":"Endocr J"},{"key":"10.1016\/j.pedneo.2019.12.009_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.1.01993","article-title":"A systematic review of drug therapy for Graves' hyperthyroidism","volume":"153","author":"Abraham","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pedneo.2019.12.009_bib29","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.pedneo.2019.12.009_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/cen.13099","article-title":"Graves' disease in children: long-term outcomes of medical therapy","volume":"85","author":"Rabon","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pedneo.2019.12.009_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1515\/jpem-2018-0495","article-title":"Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience","volume":"32","author":"Bayramo\u011flu","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2019.12.009_bib32","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/EJE-16-0938","article-title":"Management of endocrine disease: arguments for the prolonged use of antithyroid drugs in children with Graves' disease","volume":"177","author":"L\u00e9ger","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pedneo.2019.12.009_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1297\/cpe.26.29","article-title":"Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016","volume":"26","author":"Minamitani","year":"2017","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.pedneo.2019.12.009_bib34","first-page":"50","article-title":"Hyperthyroidism in childhood: causes, when and how to treat","volume":"5","author":"L\u00e9ger","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.pedneo.2019.12.009_bib35","first-page":"637","article-title":"Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling","volume":"103","author":"Kourime","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pedneo.2019.12.009_bib36","first-page":"627","article-title":"Graves' disease. Time to move on","volume":"103","author":"Cheetham","year":"2018","journal-title":"Arch Dis Child"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957219305595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957219305595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:54:18Z","timestamp":1761749658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957219305595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1875957219305595"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2019.12.009","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of graves disease in children treated with anti-thyroid drugs","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2019.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}